Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Stealth Biotherapeutics Corp ADR (MITO)

1.36   -0.01 (-0.73%) 07-29 04:55
Open: 1.36 Pre. Close: 1.37
High: 1.44 Low: 1.36
Volume: 58,730 Market Cap: 78M
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate, Elamipretide, has the potential to treat rare genetic and common age-related mitochondrial diseases. The company's product candidates include SBT-20, a small peptide that targets and binds reversibly to cardiolipin, stabilizing mitochondrial structure, and function under conditions of oxidative stress; and SBT-272, a lead discovery pipeline compound, evaluating for rare neurodegenerative diseases, such as amyotrophic lateral sclerosis. Stealth BioTherapeutics Corp was founded in 2006 and is based in George Town, the Cayman Islands.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.441 - 1.448 1.448 - 1.455
Low: 1.344 - 1.351 1.351 - 1.358
Close: 1.349 - 1.36 1.36 - 1.371

Technical analysis

as of: 2021-07-28 4:45:45 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.75     One year: 1.89
Support: Support1: 1.31    Support2: 1.09
Resistance: Resistance1: 1.50    Resistance2: 1.62
Pivot: 1.41
Moving Average: MA(5): 1.38     MA(20): 1.44
MA(100): 1.46     MA(250): 1.52
MACD: MACD(12,26): -0.04     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 18.52     %D(3): 24.59
RSI: RSI(14): 42.27
52-week: High: 2.58  Low: 1.06  Change(%): -39.0
Average Vol(K): 3-Month: 566836  10-Days: 14062

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
MITO has closed above bottom band by 29.6%. Bollinger Bands are 47.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to MITO's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 28 Jul 2021
Stealth BioTherapeutics (MITO) falls 1.46% to Close at $1.35 on July 27 -

Tue, 27 Jul 2021
Stealth BioTherapeutics (MITO) falls 4.20% to Close at $1.37 on July 26 -

Fri, 23 Jul 2021
Stealth BioTherapeutics Corp - ADR (MITO) gains 2.14% for July 23 -

Thu, 22 Jul 2021
Stealth BioTherapeutics Corp - ADR (MITO) gains 0.72% for July 22 -

Wed, 21 Jul 2021
Stealth BioTherapeutics Corp - ADR (MITO) gains 0.73% for July 21 -

Mon, 19 Jul 2021
Stealth BioTherapeutics Corp - ADR (MITO) falls 2.55% for July 19 -

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 57
Shares Float (M) 19
% Held by Insiders
% Held by Institutions 12.96
Shares Short (K) 789
Shares Short P. Month (K) 229

Stock Financials

EPS -0.976
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -0.220
Profit Margin
Operating Margin
Return on Assets (ttm) -83.5
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.780
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -1.39
PEG Ratio
Price to Book value -6.18
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.